Concepedia

Samriddhi Buxy Sinha

SB

3

Publications

46

Citations

3

H-Index

2023

Active since

Affiliations

Novartis (Switzerland)(Current)

Doheny Eye Institute

Rutgers New Jersey Medical School

Novartis (United States)

Rush University Medical Center

Samriddhi Buxy Sinha is an author at Novartis (Switzerland) specializing in glaucoma, ophthalmology, and medicine.

ORCID

Top concepts

Publications per year

2023–2023

3

Publications

3

One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry

Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 18 citations

, , +7

Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration

Joseph Coney, Ryan Zubricky, Samriddhi Buxy Sinha et al. · International Journal of Retina and Vitreous · 2023 · 16 citations · Full text

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab

Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 12 citations

Rows per page

1–3 of 3